MC

556.9

-3.33%↓

SANES

6.177

-1.92%↓

BNP

75.4

-1.39%↓

CS.FR

39.95

-0.77%↓

ALV

356.3

+0.06%↑

MC

556.9

-3.33%↓

SANES

6.177

-1.92%↓

BNP

75.4

-1.39%↓

CS.FR

39.95

-0.77%↓

ALV

356.3

+0.06%↑

MC

556.9

-3.33%↓

SANES

6.177

-1.92%↓

BNP

75.4

-1.39%↓

CS.FR

39.95

-0.77%↓

ALV

356.3

+0.06%↑

MC

556.9

-3.33%↓

SANES

6.177

-1.92%↓

BNP

75.4

-1.39%↓

CS.FR

39.95

-0.77%↓

ALV

356.3

+0.06%↑

MC

556.9

-3.33%↓

SANES

6.177

-1.92%↓

BNP

75.4

-1.39%↓

CS.FR

39.95

-0.77%↓

ALV

356.3

+0.06%↑

Search

Eurazeo SE

Open

SectorFinanciën

65.95 -2.73

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

64.25

Max

67.95

Belangrijke statistieken

By Trading Economics

Inkomsten

-105M

Verkoop

104M

Dividendrendement

3.89

Winstmarge

-100.723

EBITDA

-51M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+44.93% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

3.89%

3.90%

Volgende Winsten

10 apr 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

5.1B

Vorige openingsprijs

68.68

Vorige sluitingsprijs

65.95

Nieuwssentiment

By Acuity

41%

59%

172 / 542 Rangschikking in Finance

Technische score

By Trading Central

Vertrouwen

Strong Bearish Evidence

Eurazeo SE Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

11 sep 2024, 06:28 UTC

Acquisities, Fusies, Overnames

EQT Leads $102.5 Million Series A Funding Round in Belgian Radioisotope Producer PanTera

Peer Vergelijking

Prijswijziging

Eurazeo SE Prognose

Koersdoel

By TipRanks

44.93% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 100 EUR  44.93%

Hoogste 100 EUR

Laagste 100 EUR

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor Eurazeo SE - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

1 ratings

1

Buy

0

Hold

0

Sell

Technische score

By Trading Central

N/A / 71.95Steun & Weerstand

Korte Termijn

Strong Bearish Evidence

Gemiddeld Termijn

Strong Bearish Evidence

Lange Termijn

Bearish Evidence

Sentiment

By Acuity

172 / 542 Rangschikking in Financiën

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Eurazeo SE

Eurazeo SE is a private equity and venture capital firm specializing in growth capital, acquisitions, leveraged buyouts, and buy-ins of a private company, and investments in mid-market and listed public companies. The company invest in equity in the small-mid and Mid-large buyout segments. The firm seeks to invest in medium-sized or large companies, SMEs, high growth companies, and real estate management and investment activities. It does not have any restrictions regarding the sectors in which it invests but prefers to invest in smart cities, services, leisure and mobility, real estate, fintech, investment activities, distribution, industry, luxury, consumer goods, business services, consumer and retail brands, and health sectors. The firm seeks to invest in consumer brands with a focus on beauty, personal care, household care, juvenile products, apparel, wellness, accessories, home, jewellery, leisure, health, fitness, beverage, and food companies based in United States and Europe. It typically invests in companies with a differentiated concept and global growth potential. The firm identifies companies upstream, carefully selecting them primarily from sectors driven by digital transformation and focusing on changes in lifestyle and consumption (mobility, online buying, collaboration models, etc. The firm invests in large properties in need of restructuring; residential, commercial, and office development projects; and companies with real estate assets in Western Europe. It primarily invests in United States, France, Italy, North America and other European countries. It seeks to invest between "50 million ($54.35 million) to "250 million ($271.77 million) in small mid buyout business. It seeks to invest between "25 million ($27.18 million) to "100 million ($108.71 million) in growth business. It seeks to invest between "10 million ($10.82 million) and "40 million ($43.82 million) in the fields of healthcare research. It seeks to invests between equity investment between "1 million ($1.17 million) and "559.01 mil